DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Botox (Botulinum Toxin Type A) - Adverse Event Reports - Other Serious Reactions

 



Index of reports > Cases resulting in other serious reactions (54)

     Dysphagia (12)Botulism (10)Asthenia (8)Pneumonia Aspiration (7)Eyelid Ptosis (7)Lethargy (6)Dyspnoea (5)Muscle Spasms (5)Muscular Weakness (4)Malaise (4)

Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in other serious reactions.

 Reports 1 - 25 of 54   Next >>

Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-24

Patient: male

Adverse reactions / side effects: Botulism

Suspect drug(s):
Botox
    Indication: Muscle Spasticity

Botox
    Indication: Cerebral Palsy



Adverse event in receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-24

Patient:

Adverse reactions / side effects: Abdominal Pain, Oral Intake Reduced, Weight Decreased, Dysphagia, Pneumonia Aspiration, Incorrect Dose Administered, Muscular Weakness, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 1370 units, single
    Indication: Cerebral Palsy
    Start date: 2007-09-18
    End date: 2007-09-18

Botox
    Indication: Muscle Spasticity



Adverse event in receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-22

Patient:

Adverse reactions / side effects: Botulism

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-22

Patient: female, weighing 11.8 kg (26.0 pounds)

Adverse reactions / side effects: Overdose, Botulism

Suspect drug(s):
Botox
    Dosage: 400 units, single
    Indication: Muscle Spasticity

Botox
    Indication: Cerebral Palsy



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-22

Patient: female

Adverse reactions / side effects: Stridor, Vocal Cord Disorder

Suspect drug(s):
Botox (Botulinum Toxin Type A)

Other drugs received by patient: Succinylcholine Chloride; Oxygen



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-19

Patient: female

Adverse reactions / side effects: Endocarditis Bacterial, Bacteraemia, Sepsis

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a health professional (non-physician/pharmacist) from Australia on 2007-10-18

Patient: female

Adverse reactions / side effects: Vision Blurred, Musculoskeletal Stiffness, Hyperhidrosis

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from Finland on 2007-10-18

Patient: female

Adverse reactions / side effects: Dysphagia

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-17

Patient: female

Adverse reactions / side effects: Sepsis, Endocarditis

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from Norway on 2007-10-12

Patient: female

Adverse reactions / side effects: Balance Disorder, Pain, Paralysis, Dizziness

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-11

Patient: male, weighing 86.2 kg (189.6 pounds)

Adverse reactions / side effects: Blood Pressure Increased, Dysphagia, Dyspnoea, Pain in Extremity, Headache, Muscle Spasticity, Mantle Cell Lymphoma, Anxiety, Dysarthria, Malaise, Fatigue, Dysphonia, Neck Pain, Dizziness

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 400 units, single
    Indication: Pain
    Start date: 2007-02-06
    End date: 2007-02-06

Botox
    Indication: Dystonia

Other drugs received by patient: Celebrex; Tylenol W / Codeine NO. 3



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-10-10

Patient: female

Adverse reactions / side effects: Osteonecrosis

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from Spain on 2007-10-08

Patient: female

Adverse reactions / side effects: Dizziness

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a pharmacist from Japan on 2007-10-08

Patient: female

Adverse reactions / side effects: Pyrexia, Loss of Consciousness

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in 42 year old male receiving Botox (Botulinum Toxin Type A)

Reported by a individual with unspecified qualification from United States on 2007-10-03

Patient: 42 year old male, weighing 85.3 kg (187.6 pounds)

Adverse reactions / side effects: Weight Decreased, Hyperacusis, Tinnitus, Impaired Work Ability, Musculoskeletal Discomfort, Headache, Sensation of Pressure, Stress, Discomfort, Meniere's Disease, Anxiety, DRY Mouth, Depression, DRY Eye

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a pharmacist from Japan on 2007-07-31

Patient: female

Adverse reactions / side effects: Pyrexia, Loss of Consciousness

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-07-30

Patient: female

Adverse reactions / side effects: Dysphagia, Hepatic Failure, Rash

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-07-25

Patient: female

Adverse reactions / side effects: Trismus, Drooling, Neck Pain, Muscular Weakness, Skin Burning Sensation, Eye Disorder, Muscle Spasms

Suspect drug(s):
Botox
    Dosage: unk, single
    Indication: Facial Spasm
    Start date: 2006-09-07
    End date: 2006-09-07

Botox
    Dosage: unk, single
    Indication: Headache
    Start date: 2006-09-22
    End date: 2006-09-22

Botox
    Dosage: unk, single
    Indication: Temporomandibular Joint Syndrome
    Start date: 2006-10-06
    End date: 2006-10-06



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-24

Patient: female

Adverse reactions / side effects: Vomiting, Middle Ear Effusion, Pyrexia, Amnesia, Hyperhidrosis, Somnolence, Paraesthesia, Fatigue, Malaise, Arthralgia, Joint Swelling, Cough

Adverse event resulted in: disablity

Suspect drug(s):
Botox
    Dosage: 300 units, single
    Indication: Cluster Headache
    Start date: 2006-12-21
    End date: 2006-12-21

Botox
    Dosage: unk, single
    Start date: 2006-08-01
    End date: 2006-08-01

Other drugs received by patient: Maxalt; Lyrica; Topamax; Lidocaine



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-07-20

Patient: female, weighing 68.0 kg (149.6 pounds)

Adverse reactions / side effects: Exfoliative Rash, Precancerous Skin Lesion, Local Swelling

Suspect drug(s):
Botox

Lyrica
    Indication: Migraine
    Start date: 2007-05-01
    End date: 2007-06-01



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-07-19

Patient: male

Adverse reactions / side effects: Muscle Atrophy, Tendon Disorder, Muscle Contracture, Paralysis, Muscle Tightness

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-07-13

Patient: male, weighing 20.0 kg (44.0 pounds)

Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 600 units, single
    Indication: Muscle Spasticity
    Start date: 2007-04-23
    End date: 2007-04-23

Botox

Botox

Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-06-29

Patient: female

Adverse reactions / side effects: Eyelid Oedema, Drug Ineffective, Muscle Injury, Blindness, Haematoma

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from Sweden on 2007-06-29

Patient: female

Adverse reactions / side effects: LIP Swelling, Dyspnoea, Oedema Mouth

Suspect drug(s):
Botox
    Dosage: unk, unk
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-03-14
    End date: 2007-03-14

Botox
    Start date: 2007-03-22
    End date: 2007-03-22



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-06-28

Patient: female

Adverse reactions / side effects: Eyelid Oedema, Drug Ineffective, Muscle Injury, Blindness, Haematoma

Suspect drug(s):
Botox (Botulinum Toxin Type A)



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009